Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing

Biocept Inc (NASDAQ: BIOC)

$2.19 USD -$0.04 (-1.79%)
Last Price $2.19
Net Change $-0.04 (-1.79%)
Bid $2.19
Ask Price $2.2
Open Price $2.17
Previous Close Price $2.23
High Price $2.23
Low Price $2.16
Number of Trades 156
Volume 128,761
Fifty Two Week High $4.29 (2016-04-20)
Fifty Two Week Low $0.74 (2016-11-04)
Average Daily Volume 3,736,647
Share Outstanding 17,500 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $58.85
Recent Earnings $
Annual EPS $-2.19
Last Quarter EPS $
Market Capitalization $0.04B
Insider Shareholders % 0.068%
Annual Revenue $0B
No. Shares Outstanding 17,500
Inst. Shareholder % 5.83%
Annual Net Income $-0.02B
TTM Net Profit Margin $-571.43
1-Year Return -41.47%
3-Year Return -89.82%
5-Year Return -92.09%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 58.849998%
Dividends per Share $
Stock Split Ratio 1-3
Beta 3.04
Biocept Inc. is a commercial stage oncology diagnostics company. It has developed technology platforms for capture and analysis of circulating tumor cells and circulating tumor DNA utilizing a standard blood sample to provide physicians. The company offers OncoCEE-BR (TM) test for breast cancer. Biocept Inc. is headquartered in San Diego California.